Diffuse mesothelioma
Cytomorphologic features of well-differentiated papillary mesothelioma in peritoneal effusion: A case report
Diagnostic Cytopathology. 2008 Jun 4;36(7):512-515. [Epub ahead of print] [Link] Ikeda K, Suzuki T, Tate G, Mitsuya T. Department of Pathology, Showa University Fujigaoka Hospital, Fujigaoka, Yokohama, Japan. Abstract Well-differentiated papillary mesothelioma (WDPM), a distinct subtype of diffuse malignant mesothelioma, usually occurs in the peritoneum and is seen most commonly in women of reproductive age.…
Read MoreTargeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma
Molecular Cancer Therapeutics. 2008 Apr;7(4):788-99. Epub 2008 Mar 28. [Link] Miselis NR, Wu ZJ, Van Rooijen N, Kane AB. Department of Pathology and Laboratory Medicine, Brown University, Box G-E531, Providence, RI 02912. Nathan_Miselis@brown.edu. Abstract Tumors are a mixture of neoplastic and host stromal cells, which establish a microenvironment that contributes to tumor progression. In this…
Read MoreFrom the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation
RadioGraphics. 2008 Mar-Apr;28(2):583-607; quiz 621-2. [Link] Levy AD, Arnáiz J, Shaw JC, Sobin LH. Department of Radiology and Radiological Sciences, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD 20814-4799, USA. alevy@usuhs.mil Abstract Primary peritoneal tumors are uncommon lesions that arise from the mesothelial or submesothelial layers of the peritoneum. Primary…
Read MoreCytologic malignancy versus benignancy: how useful are the “newer” markers in body fluid cytology?
Archives of Pathology and Laboratory Medicine. 2008 Jan;132(1):23-8. [Link] Lyons-Boudreaux V, Mody DR, Zhai J, Coffey D. Weill Medical College of Cornell University, The Methodist Hospital, Department of Pathology, Houston, TX 77030, USA. Abstract Context: Differentiating reactive effusion, malignant mesothelioma, and metastatic adenocarcinoma in body cavity fluids can be challenging. Interpreting immunohistochemical markers in cell…
Read MoreEarly cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: A case report
Diagnostic Cytopathology. 2008 Feb;36(2):120-3. [Link] Pomjanski N, Grote HJ, Sander O, Heikaus S, Müller KM, Böcking A. Institute of Cytopathology, Heinrich-Heine University Düsseldorf, Germany. Abstract Mesotheliomas are the most frequent primary malignant tumors of serosal cavities with a poor prognosis. A definitive and early diagnosis on effusion samples is important, because recent advances in therapy…
Read MoreAcne inversa complicated by squamous cell carcinoma in association with diffuse malignant peritoneal mesothelioma arising in the absence of predisposing factors: a case report
Journal of Cutaneous Pathology. 2008 Jan;35(1):70-3. [Epub ahead of print] [Link] Barresi V, Vitarelli E, Barresi G. Dipartimento di Patologia Umana, Policlinico Universitario G. Martino, University of Messina, Italy. Abstract Diffuse malignant peritoneal mesothelioma (DMPM) is a relatively rare neoplasm. Risk factors associated with its development include asbestos exposure, chronic irritation or inflammation of the…
Read MoreImmunohistochemical Detection of XIAP in Mesothelium and Mesothelial Lesions
American Journal of Clinical Pathology. 2007 Nov;128(5):783-7. [Link] Wu M, Sun Y, Li G, Desman G, Wang B, Gil J, Burstein DE. Department of Pathology, Mount Sinai School of Medicine, New York University, New York, NY 10029-6574, USA. Abstract We examined benign and malignant mesothelial tissue samples for the presence of X-linked inhibitor of apoptosis…
Read MoreMulticystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC)
Annals of Surgical Oncology. 2007 Oct;14(10):2790-7. Epub 2007 Jul 28. [Link] Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M. Department of Surgery, National Cancer Institute, Milan, Italy. Abstract Background: Multicystic peritoneal mesothelioma (MPM) and well-differentiated papillary peritoneal mesothelioma (WDPPM) are exceedingly uncommon lesions with uncertain malignant potential and no uniform treatment…
Read MoreSo13p cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma – analysis of 100 consecutive patients from a prospective database
ANZ Journal of Surgery. 2007 May;77 Suppl 1:A88-9. [Link] Yan TD, Sim J, Sugarbaker PH. St. George Hospital, New South Wales, Australia. Abstract Purpose: Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and invariably fatal neoplasm. Some studies have shown that cytoreductive surgery (CRS) combined with perioperative intraperitoneal chemotherapy (PIC) achieved an improved survival, as…
Read MoreLate-onset chylothorax following extrapleural pneumonectomy for mesothelioma
General Thoracic and Cardiovascular Surgery. 2007 Feb;55(2):50-2. [Link] Tokunaga T, Inoue M, Ideguchi K, Okumura M, Sawa Y. Division of Thoracic and Cardiovascular Surgery, Department of Surgery (E1), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan. Abstract We report a 64-year-old woman treated with surgical intervention for late-onset chylothorax following a pleuropneumonectomy.…
Read More